Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,205.1
16.6 (0.52%)

 

  • STI Straits Times Index
    3,205.1
    16.6 (0.52%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,588.1
    -3.5 (-0.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,126.9
    109.4 (0.42%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,582.6
    -12.2 (-0.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,804.8
    96.3 (0.34%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,643.7
    10.8 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,256.9M
  • Value: 811.0M
  • Rise: 183
  • Fall: 150
  • Unch: 418

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.068-0.003
King Wan0.055-0.002
Boldtek0.084+0.020
Sembcorp Marine0.079-0.001
Sinjia Land0.086+0.007
Raffles Edu0.071+0.010
Rex Intl0.345-0.005
ThaiBev0.715+0.010
Shen Yao0.002-0.001
No Signboard0.052-

World Indices

World Indices
Name Last Change
Nasdaq 15,090.2 -125.5
HSI 26,126.9 +109.4
HSCEI 9,356.9 +83.3
Jakarta 6,643.7 +10.8
Nikkei 225 28,804.8 +96.3
SSE Comp 3,582.6 -12.2
Shanghai A 3,754.7 -12.7
Shanghai B 275.7 -1.8
KOSPI 3,006.2 -1.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SOMNOMED LIMITED SOMNOMED
Updated on 22 Oct 2021 (End of trading day)
Last (AUD): 2.430 Change: +0.080 High: 2.430 Remarks: -
Change (%): +3.40 Low: 2.270
Open 2.340 Yesterday's Close 2.35
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 79,038 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.01442 Trailing EPS (AUD) e -0.01442 NAV (AUD) b 0.3886
PE a - Trailing PE f - Price / NAV b 6.2532
Dividend (AUD) d - Cash In Hand (AUD) g 0.2551 Issued & Paid-up Shares c 82,759,300
Dividend Yield (%) d - Price / Cash In Hand g 9.526 Treasury Shares h -
Beta - 75 Daysi -0.093 R-Squared - 75 Days(%)i 0.51 Market Cap (M) 201.105
Beta - 500 Daysi 0.490 R-Squared - 500 Days (%)i 1.14 Enterprise Value (M) 188.903
Piotroski F Score 5 Exchange Code SOM Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 44.71 Free Float (%) 67.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 30 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SOMNOMED LIMITED ASX 201.105 - - 6.2532 -
Industry Medical Specialties ASX 2,200.447 66.267 65.690 9.5626 0.850
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 17,024.416 34.780 34.780 12.1736 1.413
Local Peer COCHLEAR LTD ASX 14,651.404 44.874 44.874 8.6099 1.144
Local Peer EBOS GROUP ASX 5,467.294 29.506 29.506 3.8747 2.582
Local Peer NANOSONICS LIMITED ASX 1,749.402 203.938 203.941 12.9032 -
Local Peer METRICS INCOME OPPORTUNITIES TRUST ASX 600.218 - - -420.4082 -
Local Peer INCANNEX HEALTHCARE LTD ASX 429.028 - - 50.0000 -
Local Peer AROA BIOSURGERY LTD ASX 399.980 - - 7.4380 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 350.024 - - 5.1247 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 316.705 - - - -
Local Peer CLARITY PHARMACEUTICALS LTD ASX 289.430 - - 14.2677 -
Local Peer IMPEDIMED LIMITED ASX 254.507 - - 10.0000 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 214.174 - - 21.3091 -
Other Local Peers ATOMO DIAGNOSTICS LIMITED (ASX), CYCLOPHARM LIMITED (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), MICRO-X LTD (ASX), OPTISCAN IMAGING (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), CLEANSPACE HOLDINGS LTD (ASX), SDI LTD (ASX), DIMERIX LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), COMPUMEDICS (ASX), CARDIEX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESONANCE HEALTH LTD (ASX), RESPIRI LTD (ASX), LBT INNOVATIONS LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), TRUSCREEN GROUP LTD (ASX), OVENTUS MEDICAL LTD (ASX), ADHERIUM LIMITED (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), ANALYTICA (ASX)
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 240,756.691 37.766 28.008 6.5327 0.145
Global Peer DANAHER CORP NYSE 223,934.140 63.799 63.799 5.6709 0.229
Global Peer ABBOTT LABORATORIES NYSE 224,651.750 50.224 43.877 - 1.206
Global Peer MEDTRONIC PLC NYSE 165,655.753 45.939 42.662 3.2175 1.965
Global Peer INTUITIVE SURGICAL INC NASDAQ 121,913.077 114.947 72.172 10.6386 -
Global Peer STRYKER CORP NYSE 103,976.680 65.026 49.917 7.5236 0.852
Global Peer EDWARDS LIFESCIENCES CORP NYSE 72,673.812 88.261 49.695 14.1573 -
Global Peer BECTON DICKINSON & CO NYSE 70,961.777 92.518 38.049 2.9404 1.308
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,845.434 - 136.422 4.0049 -
Global Peer DEXCOM INC NASDAQ 54,815.024 111.051 103.308 27.4404 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), WATERS CORP (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), ABIOMED INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), NOVOCURE LTD (NASDAQ), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), TANDEM DIABETES CARE INC (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), GLOBUS MED INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ANGELALIGN TECHNOLOGY INC (HKEx), STEVANATO GROUP S.P.A. (NYSE), INMODE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), NEVRO CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), CAREDX INC (NASDAQ), HAEMONETICS CORP (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), GLAUKOS CORPORATION (NYSE), LIFETECH SCIENTIFIC CORP (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), BUTTERFLY NETWORK INC (NYSE), BIOLIFE SOLUTIONS INC (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), PEIJIA MEDICAL LIMITED (HKEx), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), LANTHEUS HOLDINGS INC (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), CUE HEALTH INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), PULMONX CORPORATION (NASDAQ), PARAGON 28 INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), SUPERMX (Bursa), ORTHOPEDIATRICS CORP (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), SIGHT SCIENCES INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VIEWRAY INC (NASDAQ), CERUS CORP (NASDAQ), VICARIOUS SURGICAL INC (NYSE), VAREX IMAGING CORPORATION (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), 908 DEVICES INC (NASDAQ), INOGEN INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), SEMLER SCIENTIFIC INC (NASDAQ), DERMTECH INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), SISRAM MEDICAL LTD (HKEx), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), BIOVENTUS INC (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CUTERA INC (NASDAQ), SURMODICS INC (NASDAQ), SI BONE INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), INTERCURE LTD (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), NYXOAH SA (NASDAQ), VAPOTHERM INC (NYSE), SEASPINE HOLDINGS CORP (NASDAQ), PAVMED INC (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), IRADIMED CORP (NASDAQ), STEREOTAXIS INC (NYSE American), MISONIX INC (NASDAQ), SOLITON INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), ACCELERATE DIAGNOSTICS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), EARGO INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), NEUROPACE INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), SIENTRA INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ONCOCYTE CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CVRX INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), PROFOUND MED CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), QUOTIENT LTD (NASDAQ), DARIOHEALTH CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), CONFORMIS INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), CORMEDIX INC (NASDAQ), TELA BIO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), INVACARE CORP (NYSE), INTRICOM CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), UGHealthcare (SGX), Medtecs Intl (SGX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), NEURONETICS INC (NASDAQ), KELFRED HOLDINGS LTD (HKEx), NEMAURA MEDICAL INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IRIDEX CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), FONAR CORP (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), RGTBHD (Bursa), ALPHA PRO TECH (NYSE American), VOLITIONRX LIMITED (NYSE American), ENVVENO MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), BIOLASE INC (NASDAQ), CHECK-CAP LTD (NASDAQ), ELECTROMED INC (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), LENSAR INC (NASDAQ), CELSION CORPORATION (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), IMMUCELL CORP (NASDAQ), AVINGER INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), CHEMBIO DIAGNOSTICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), BIOMERICA INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NEOVASC INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), NEUROMETRIX INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), DAXOR CORP (NYSE American), NUTRIBAND INC (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), TENAX THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), Biolidics (SGX), ADVENTA (Bursa), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), Yunnan Energy (SGX), INSPIREMD INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), LKL (Bursa), LIFE HEALTHCARE GROUP LTD (HKEx), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), THERMOGENESIS HOLDINGS INC (NASDAQ), NUWELLIS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), CYANOTECH CORP (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), Annica (SGX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.210
+9.46 %
10 Days -+0.080
+3.40 %
20 Days -+0.080
+3.40 %
Medium Term Return 3 Months -+0.130
+5.65 %
6 Months -+0.430
+21.50 %
1 Year -+0.140
+6.11 %
Long Term Return 2 Years -+0.292
+13.66 %
3 Years -+1.074
+79.20 %
5 Years --0.968
-28.49 %
Annualised Return Annualised --
-6.49 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.725 - 2.500 Change From 1 Year Low +0.705 % Change From 1 Year Low (%) +40.87
Change From 1 Year High -0.070 % Change From 1 Year High (%) -2.80
2 Years Range 0.900 - 2.953 Change From 2 Years Low +1.530 % Change From 2 Years Low (%) +170.00
Change From 2 Years High -0.523 % Change From 2 Years High (%) -17.72
5 Years Range 0.900 - 3.432 Change From 5 Years Low +1.530 % Change From 5 Years Low (%) +170.00
Change From 5 Years High -1.002 % Change From 5 Years High (%) -29.20
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep disordered breathing relieving conditions. The company was founded on March 16, 1987 and is headquartered in Sydney, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
22 Oct 2021 2.340 2.430 2.270 2.430 79,038 -
21 Oct 2021 2.350 2.350 2.350 2.350 1,265 -
20 Oct 2021 2.210 2.350 2.210 2.350 2,605 -
19 Oct 2021 2.190 2.220 2.190 2.220 3,486 -
18 Oct 2021 2.220 2.220 2.190 2.190 2,083 -
15 Oct 2021 2.190 2.220 2.190 2.220 3,178 -
14 Oct 2021 2.180 2.180 2.180 2.180 - -
13 Oct 2021 2.180 2.250 2.180 2.180 29,843 -
12 Oct 2021 2.350 2.350 2.350 2.350 - -
11 Oct 2021 2.350 2.350 2.350 2.350 - -
08 Oct 2021 2.350 2.350 2.350 2.350 3,442 -
07 Oct 2021 2.300 2.370 2.300 2.300 2,857 -
06 Oct 2021 2.400 2.400 2.400 2.400 - -
05 Oct 2021 2.400 2.400 2.400 2.400 - -
04 Oct 2021 2.370 2.400 2.360 2.400 12,716 -
01 Oct 2021 2.350 2.350 2.350 2.350 - -
30 Sep 2021 2.300 2.350 2.210 2.350 34,063 -
29 Sep 2021 2.400 2.410 2.400 2.400 34,808 -
28 Sep 2021 2.400 2.420 2.400 2.420 8,440 -
27 Sep 2021 2.380 2.400 2.380 2.400 33,455 -
24 Sep 2021 2.300 2.390 2.300 2.350 24,885 -
23 Sep 2021 2.320 2.320 2.300 2.320 517,989 -
Summary
Current 2 Weeks
(11 Oct 2021 to 22 Oct 2021)
2.350 2.430 2.180 2.430 121,498 -
Previous 2 Weeks
(27 Sep 2021 to 08 Oct 2021)
2.380 2.430 2.180 2.350 129,781 -
4 Weeks from
(30 Aug 2021 to 24 Sep 2021)
2.260 2.430 2.180 2.350 847,096 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.